These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15951613)

  • 21. Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E687-92. PubMed ID: 17062843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of human immunodeficiency virus-1 infected children receiving highly active antiretroviral therapy: a cross-sectional study].
    Badillo K; Prieto L; Toledano M; Guillen S; Alvarez A; García Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2012 Jun; 76(6):317-23. PubMed ID: 22326511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy.
    Bard JM; Lassalle R; Capeau J; Bach-Ngohou K; Nazih-Sanderson F; Rémy G; Reynes J; Ecobichon JL; Savès M; Raffi F;
    Antivir Ther; 2006; 11(3):361-70. PubMed ID: 16759053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipodystrophy in children and adolescents with acquired immunodeficiency syndrome and its relationship with the antiretroviral therapy employed.
    Sarni RO; Souza FI; Battistini TR; Pitta TS; Fernandes AP; Tardini PC; Fonseca FL; Dos Santos VP; Lopez FA
    J Pediatr (Rio J); 2009; 85(4):329-34. PubMed ID: 19668909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazolidinediones in the treatment of HIV/HAART-associated lipodystrophy syndrome.
    Edgeworth A; Treacy MP; Hurst TP
    AIDS Rev; 2013; 15(3):171-80. PubMed ID: 24002201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.
    Domingo P; Estrada V; López-Aldeguer J; Villaroya F; Martínez E
    AIDS Rev; 2012; 14(2):112-23. PubMed ID: 22627607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
    Wierzbicki AS; Purdon SD; Hardman TC; Kulasegaram R; Peters BS
    Curr Med Res Opin; 2008 Mar; 24(3):609-24. PubMed ID: 18208641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy.
    Dejkhamron P; Unachak K; Aurpibul L; Sirisanthana V
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):403-12. PubMed ID: 24259240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
    Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
    Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
    Calza L; Manfredi R; Pocaterra D; Chiodo F
    J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum leptin concentrations and fat redistribution in HIV-1-infected children on highly active antiretroviral therapy.
    Dzwonek AB; Novelli V; Schwenk A
    HIV Med; 2007 Oct; 8(7):433-8. PubMed ID: 17760735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
    Tao MM; Zhang L; Qiu ZF; Xie J; Han Y; Yu W; Li M; Li TS
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):867-71. PubMed ID: 19671283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome.
    Verkauskiene R; Dollfus C; Levine M; Faye A; Deghmoun S; Houang M; Chevenne D; Bresson JL; Blanche S; Lévy-Marchal C
    Pediatr Res; 2006 Aug; 60(2):225-30. PubMed ID: 16864709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipodystrophy syndrome in human immunodeficiency virus-infected children.
    Amaya RA; Kozinetz CA; McMeans A; Schwarzwald H; Kline MW
    Pediatr Infect Dis J; 2002 May; 21(5):405-10. PubMed ID: 12150177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in leptin serum levels in HIV-infected children receiving highly active antiretroviral therapy.
    Papaevangelou V; Papassotiriou I; Vounatsou M; Chrousos G; Theodoridou M
    Scand J Clin Lab Invest; 2007; 67(3):291-6. PubMed ID: 17454843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy.
    Werner ML; Pone MV; Fonseca VM; Chaves CR
    J Pediatr (Rio J); 2010; 86(1):27-32. PubMed ID: 20151093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity.
    Villarroya F; Domingo P; Giralt M
    Trends Pharmacol Sci; 2005 Feb; 26(2):88-93. PubMed ID: 15681026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.